<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Annexins are a group of calcium- and <z:chebi fb="0" ids="16247">phospholipid</z:chebi>-dependent proteins </plain></SENT>
<SENT sid="1" pm="."><plain>As a member of the annexin, annexin A2 (Anxa2) is widely distributed in nucleus, cytoplasm and extracellular surface and mainly expressed in human endothelial cells, mononuclear cells, macrophages, marrow cells and some <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> cells </plain></SENT>
<SENT sid="2" pm="."><plain>Accumulated evidences indicated that Anxa2 deregulation was associated with the occurrence, invasion and <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e> of <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancers</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>Anxa2 up-regulation was related to the development, invasion, <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e> and drug resistance of <z:hpo ids='HP_0001402'>hepatocellular carcinoma</z:hpo>, <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e>, <z:hpo ids='HP_0003002'>breast cancer</z:hpo>, <z:hpo ids='HP_0002894'>pancreatic cancer</z:hpo>, <z:hpo ids='HP_0004836'>acute promyelocytic leukemia</z:hpo> and <z:hpo ids='HP_0005584'>renal cell carcinoma</z:hpo>; while Anxa2 down-regulation was associated with <z:hpo ids='HP_0012125'>prostate cancer</z:hpo>, esophageal squamous <z:mp ids='MP_0002038'>carcinoma</z:mp> and nasopharyngeal <z:mp ids='MP_0002038'>carcinoma</z:mp> and sinonasal <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> </plain></SENT>
<SENT sid="4" pm="."><plain>The association between Anxa2 and <z:mp ids='MP_0002018'>malignant tumors</z:mp> as well as the potential action mechanisms were summarized in current work </plain></SENT>
<SENT sid="5" pm="."><plain>Anxa2 might be used as a potential biomarker for the diagnosis, treatment and prognosis of certain <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> </plain></SENT>
</text></document>